Johnson & Johnson (US)

Selected Johnson & Johnson advertising

Best-known for babycare and Band-Aids, Johnson & Johnson has long been one of the world's biggest healthcare manufacturers, and got even bigger in 2006 with the purchase of the consumer health division of Pfizer. In fact, consumer products had until then been the group's smallest segment. The largest chunk of group revenues still comes from pharmaceuticals, including blockbusters such as Remicade, Procrit and Risperdal, and medical devices. The group flavours a highly decentralised structure with a broad portfolio of almost 200 separately branded subsidiary businesses, operating as McNeil, Janssen, Depuy and Ethicon among many others. Key brands under the group's umbrella include Tylenol, Neutrogena, Aveeno and Ortho contraceptives, as well as medical devices, surgical products and Acuevue contact lenses. Despite its size, Johnson & Johnson has endured tough trading in recent years, especially in the US, as a result of a series of manufacturing problems and product recalls that have tainted the reputations of several of its best-known consumer brands. 

Recent stories from Adbrands Weekly Update:

Adbrands Weekly Update 3rd Apr 2014: One of Johnson & Johnson's top centralised marketers, Kim Kadlec, has resigned as VP, worldwide marketing to join AOL as head of relationships management.

Adbrands Weekly Update 13th Mar 2014: Reckitt Benckiser acquired global rights to the K-Y "intimate lubricant" brand from Johnson & Johnson for a reported $240m. It will pair the brand with its existing Durex business, best-known worldwide for condoms, but which now has its own line of lubricants under the Durex Play banner. K-Y currently generates around $100m a year in sales, almost 70% of which are generated in North America and Brazil. Johnson & Johnson will continue to manufacture all K-Y products under contract. RB has also been linked to a possible bid for Merck & Co's OTC healthcare business, which includes US rights to the Scholl brand (which Reckitt controls in Europe), Coppertone suncare and other products.

Adbrands Weekly Update 3rd Feb 2014: Healthcare giant Johnson & Johnson reported another year of record performance, boosted by strong pharma growth and the acquisition of medical devices manufacturer Synthes. Revenues rose 6% to a best-ever $71.3bn, while net income jumped 27% to $13.8bn. The strongest growth came from pharmaceuticals where sales jumped 11% to $28.1bn, catching up with the mammoth medical devices division at $28.5bn. There was also slow but steady recovery in the group's troubled consumer healthcare business, still trying to recover ground lost in a series of US product calls. Overall global consumer healthcare growth was under 2%, but the badly dented US OTC business outperformed with a very healthy 20% jump offset by declines in other units.

Adbrands Weekly Update 7th Nov 2013: Deutsch returned to the Johnson & Johnson roster, replacing IPG stablemate McCann on the Acuevue account. 

Adbrands Weekly Update 7th Nov 2013: Johnson & Johnson is to pay fines and settlements totaling $2.2bn to US regulators for off-label promotions - where medicines are prescribed for illnesses for which they have not been licensed - and kickbacks to doctors and pharmacists covering several drugs including the anti-psychotic Risperdal. It is the third largest pharmaceutical-related settlement in US history after GSK's 2012 fine of $3bn and a $2.3bn deal with Pfizer in 2009. Johnson & Johnson also agreed to submit itself to a five-year "corporate integrity" agreement, allowing the Department of Health & Social Services to scrutinise its ongoing business operations to ensure no further contravention.

Adbrands Weekly Update 31st Oct 2013: Alison Lewis, who resigned last week from her role as CMO at Coca-Cola North America, revealed that she has accepted the job of global chief marketing officer for Johnson & Johnson consumer companies, overseeing marketing for a huge range of products from Band-aid and Listerine to Neutrogena and Tylenol. 

Which agencies handle advertising for Johnson & Johnson? Find out more from Account Assignments

Who are the competitors of Johnson & Johnson? See Pharmaceutical Sector and Personal Care Sector indexes

Latest news about Johnson & Johnson? Click here for recent headlines from Adbrands Weekly Update

Subscribers only: Adbrands profile Account assignments and selected regional contact information

Adbrands Company Profiles provide a detailed analysis of the history and current operations of leading advertisers, agencies and brands worldwide, and include a critical summary which identifies key strengths and weaknesses. Adbrands Account Assignments tracks account management for the world's leading brands and companies, including details of which advertising agency handles which accounts in which countries for major markets. 

Subscribers may access the following website links:

Johnson & Johnson website

Consumer Products

Johnson's Baby Imodium
Band-Aid Nizoral
Clean & Clear Simply Stuffy Aflexa
Tylenol StayFree


St Joseph Reach
Serenity Sucralose
Splenda Benecol
Lactaid Viactiv
Johnson & Johnson - Merck Consumer Pharmaceuticals Mylanta
Pepcid Piz Buin
RoC Neutrogena
LifeScan Woelm Pharma
Terzolin Dolormin


Ortho-McNeil Pharmaceutical Retin-a Micro
Monistat Renova
Procrit Janssenk-Cilag
Risperdal Sporanox
Janssen Pharmaceutica Alza Corporation
Ditropan XL Centocor
Ethyol Concerta

Medical Devices

Johnson & Johnson Medical Codman
DePuy Johnson & Johnson Orthopaedics
Acuevue Indigo Medical
Sterrad Cordis
Ethicon Endo-Surgery Ethicon
Dermabond Gynecare

Subscribe to and access the profile and website links All rights reserved Mind Advertising Ltd 1998-2014